FIRST LIGHT ACQU(FLAG) - 2023 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: CALIDI BIOTHERAPEUTICS, INC. (Exact name of registrant as specified in its charter) | Delaware | 86-2967193 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | i ...